All In Biotech

Drug Trial Radar · NCT03333057

Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)

A Phase 2, Multi-Center, Randomized, Double-Masked, Saline-Controlled Study to Evaluate the Effect of Perfluorohexyloctane (NOV03) at Two Different Dosing Regimens on Signs and Symptoms of Dry Eye Disease (DED)

Last checked: Nov 20, 2026Latest source record: Jan 4, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 336 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

336

Actual

Start

Jan 3, 2018

Primary completion

May 18, 2018

Study completion Jul 27, 2018

Sponsor

Lead sponsor
Novaliq GmbHIndustry
Sponsor type
Industry
First posted
Nov 6, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the efficacy, safety and tolerability of perfluorohexyloctane (NOV03) at two different dosing regimens compared to saline solution in subjects with Dry Eye Disease (DED).

Conditions

  • Dry Eye Disease (DED)

Interventions

  • NOV03Drug

    Perfluorohexyloctane

  • PlaceboDrug

    Saline solution (0.9% sodium chloride solution)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Corneal Fluorescein Staining (CFS) Total (National Eye Institute (NEI) Grading)Time frame: baseline and 2 months

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Investigational site

    Artesia, California

  • Investigational Site

    Newport Beach, California

  • Investigational Site

    Newport Beach, California

  • Investigational Site

    Santa Ana, California

  • Investigational Site

    Torrance, California

  • Investigational site

    Jacksonville, Florida

  • Investigational Site

    Lake Villa, Illinois

  • Investigational Site

    Kansas City, Missouri

  • Investigational Site

    Pennington, New Jersey

  • Investigational Site

    Nashville, Tennessee

  • Investigational Site

    Nashville, Tennessee

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.